Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine TAP Block vs Local Infiltration in Laparoscopic Abdominal Surgery
NCT05995301Completed
- Sponsor
- National Academy of Medical Sciences (India)
- Start
- Mar 2022
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by National Academy of Medical Sciences (India). Primary endpoint: Duration of analgesia at 24 hours. Started Mar 2022; status: completed.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05995301.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05995301.